ST3GAL5 and nonpapillary renal cell carcinoma: ST3GAL5 overexpression was identified to successfully predict poor prognosis and CD8+ T cell exhaustion in ccRCC, which was further validated in our own cohort using immunohistochemistry and immunofluorescence staining methods.